Startup profile for Camber: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Camber funding, valuation and investors

AI-powered revenue cycle and insurance billing for specialty care clinics.

Keep track of Camber

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$30M · February 2025

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$30M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · New York, New York

Investors in latest funding

Lead: Andreessen Horowitz

Other: Craft Ventures

Sources: latest funding Last verified: 2026-07-25

Overview

Camber (formerly Juniper) provides AI-powered revenue cycle management and insurance billing automation for specialty care clinics — ABA therapy, physical therapy, ENT, and similar verticals.

Why Camber is interesting

Operator-founded RCM with ~95% first-pass collection on $2B+ claims processed — a16z doubled down from angel through Series B.

Product & use cases

AI-powered revenue cycle management for specialty clinics — ABA therapy, physical therapy, ENT — automating insurance billing and claims.

  • Insurance claims submission for ABA therapy clinics
  • Automated billing for physical therapy practices
  • Specialty clinic collections with high first-pass rates

Key facts

  • Series B (Feb 2025): $30M led by a16z; Craft and YC among participants (Morningstar/Businesswire)
  • Total raised $50M for specialty-care revenue cycle (ABA, PT, ENT billing)
  • Co-investors not in VCT directory: ACME Capital, K Ventures
  • Source: https://www.camber.health/company/news/announcing-camber

Funding history (newest first)

Investors in our directory

Funds linked from Camber's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Operator-founded RCM with ~95% first-pass collection on $2B+ claims processed — a16z doubled down from angel through Series B.

Specialty clinics bleed margin on denied claims. Camber targets vertical-specific RCM where generic vendors underperform on payer rules.

  • Athenahealth incumbent

    Broad RCM for healthcare practices.

  • Kareo adjacent

    Practice management with billing modules.

  • Generic RCM vendors direct

    Horizontal billing without specialty-specific workflows.

Notable stories

  • Rebranded from Juniper to Camber in 2025.
  • Reports ~95% first-pass collection on $2B+ claims processed.
  • Operator-founded with YC and Craft Ventures backing.

Industries

Healthtech Fintech

Related funding articles

Venture Capital Tracker pieces that cover Camber's financing or category context.

FAQs about Camber

Practical answers founders, operators, and investors typically search for.

Camber automates insurance billing, claims submission, and collections for specialty healthcare clinics, reporting high first-pass collection rates on billions in processed claims.
Andreessen Horowitz (see /fund/andreessen-horowitz) led the $30M Series B in February 2025. Craft Ventures (see /fund/craft-ventures) participated alongside Y Combinator.
Series B ($30M, February 2025; ~$50M total raised). Operator-founded; remains private.
Specialty clinics bleed margin on denied claims — Camber targets vertical-specific RCM with AI where generic billing vendors underperform.
No — Camber remains private.
Headquarters not publicly disclosed in sources we index.
Founding year not publicly disclosed in sources we index.
Camber has not publicly disclosed profitability.
See fundraising rounds and highlights on this profile for disclosed amounts.
healthtech, fintech

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.